FDA
approval
· 2012-08-10
FDA Approved: ETRAVIRINE — Supplemental Application (Patriot Pharmaceuticals)
Summary
The FDA approved a supplemental application for etravirine filed by Patriot Pharmaceuticals, updating the drug's labeling for HIV-1 infection treatment.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
SUPPL AP for ETRAVIRINE (ETRAVIRINE)